0 likes | 2 Views
Gain insights into the global cost variations for radio-ligand therapy, a cutting-edge treatment for cancers like prostate and neuroendocrine tumors. Compare expenses across regions and understand factors influencing pricing to make informed healthcare decisions.
E N D
Nuclear Medicine Centre FMRi Gurugram INDIA Dr. Ishita B Sen Global Cost Comparison for Radio-Ligand Therapy www.nuclearmedicinetherapy.in
Overview of Radio-Ligand Therapy (RLT) • RLT is a targeted treatment for advanced cancers. • Uses radioactive ligands to destroy cancer cells. • Commonly used for prostate cancer and neuroendocrine tumors.
Factors Influencing RLT Costs • Type of cancer and stage of disease. • Specific radioisotope used (e.g., Lu-177, Ac-225). • Location of treatment facility (Fortis Memorial Research Institute (FMRI, Gurgaon(Haryana), India). • Availability of advanced nuclear medicine infrastructure.
Cost Comparison (Global Overview) • United States: $80,000 - $120,000 per treatment cycle. • Europe: $50,000 - $70,000 per cycle. • India: $7,000 - $12,000 per cycle. • India offers high-quality RLT at significantly lower costs, attracting international patients.
Benefits of Choosing India for RLT • Access to expert nuclear medicine specialists. • State-of-the-art facilities with advanced technology. • Cost savings without compromising quality. • Shorter waiting times compared to Western countries.
For more information talk to Dr. Ishita B Sen today. dr.ishitasen@nuclearmedicinetherapy.in +91 8700 668 431 www.nuclearmedicinetherapy.in